Health Alert:

Coronavirus Information: Vaccinations | Testing | Safety Policies & Visitor Guidelines | Appointments & Scheduling | FAQs

Covid Calls

Vaccine Scheduling Update: We’re experiencing very high call volumes from people interested in getting the COVID-19 vaccine. Currently, our vaccine supply is very small, and we are unable to accept phone calls to schedule vaccine appointments. Please check back here for updates.

The Gastrointestinal Cancer Risk Evaluation Program (GI-CREP) at Abramson Cancer Center offers comprehensive information, evaluation and support for patients who may be at an increased risk for developing gastrointestinal cancer (such as colon, gastric, or pancreatic cancer) and/or gastrointestinal polyps due to a hereditary syndrome.

Following your evaluation, our clinical team provides an expert assessment and a plan for managing your gastrointestinal cancer risk.

The Gastrointestinal Cancer Risk Evaluation Program team leads cancer genetics research, and participates in ongoing education. Our clinical team values internal collaboration, meeting regularly with other cancer specialists at Penn Medicine.

Learn more about the Gastrointestinal Cancer Risk Evaluation Program

Share This Page: